New NOK 1 Billion Oslo Cancer Cluster Innovation Park Opens

Prime Minister of Norway, Erna Solberg, today opened the Oslo Cancer Cluster Innovation Park. A NOK 1 billion public-private investment, the Innovation Park brings together the research, healthcare and industry partners in the Oslo oncology value chain with the Ullern High School.

This Smart News Release features multimedia. View the full release here:

The new NOK1 billion Oslo Cancer Cluster Innovation Park opened August 24, 2015 (Photo: Business Wir …

The new NOK1 billion Oslo Cancer Cluster Innovation Park opened August 24, 2015 (Photo: Business Wire)

The vision of the Oslo Cancer Cluster Innovation Park is to create Europe’s leading environment for education, research and industry within oncology, while also shortening the time it takes to develop new cancer medication and diagnostics.

The founder and driving force of the Oslo Cancer Cluster Innovation Park, Jónas Einarsson says:

“This unique project is built on private and public enthusiasm and continues the long history of integrated and translational cancer research and treatment performed at the Norwegian Radium Hospital. The Innovation Park includes Ullern High School, The Cancer Registry of Norway, Oslo Cancer Cluster Incubator, and Institute for Medical Informatics and Pathology at Oslo University Hospital – as well as global biopharmaceutical and biotech companies.”

The total investment in the building is NOK 1 billion; one fourth founded by Siva, the Norwegian state’s vehicle for developing new businesses and knowledge communities, and two-thirds private funding raised in collaboration by OBOS, Industrifinans, Radium Hospitalets Legater and Utstillingsplassen Eiendom.

“We are honoured to have Prime Minister Erna Solberg opening Oslo Cancer Cluster Innovation Park,“ says Arne Baumann, Chairman of the Board of the Innovation Park. “We look forward to showing everyone the uniqueness of this project. Oslo Cancer Cluster Innovation Park integrates education, excellent research and innovations and will further strengthen the vibrant and innovative oncology biotech milieu in Norway.”

“The communities surrounding Oslo Cancer Cluster are capable of triggering substantial innovation and international economic growth. Bringing medical research quicker from lab to market also comes with the possibility of adding global social value, ” says Espen Susegg, President at Siva.

Unlike other Innovation Parks, the Oslo Cancer Cluster Innovation Park will integrate a High School, namely Ullern High School. This will give the students the opportunity to hear guest lectures from oncology researchers and industry leaders, do internships at Oslo University Hospital and the other members of Oslo Cancer Cluster. “In this way, we hope to inspire future generations of researchers,” says Einarsson.